Growth Metrics

Idexx Laboratories (IDXX) Depreciation & Amortization (CF) (2016 - 2026)

Idexx Laboratories has reported Depreciation & Amortization (CF) over the past 17 years, most recently at $38.7 million for Q4 2025.

  • For Q4 2025, Depreciation & Amortization (CF) rose 14.88% year-over-year to $38.7 million; the TTM value through Dec 2025 reached $145.2 million, up 11.73%, while the annual FY2025 figure was $145.2 million, 11.73% up from the prior year.
  • Depreciation & Amortization (CF) for Q4 2025 was $38.7 million at Idexx Laboratories, up from $36.6 million in the prior quarter.
  • Over five years, Depreciation & Amortization (CF) peaked at $38.7 million in Q4 2025 and troughed at $25.1 million in Q1 2021.
  • A 5-year average of $30.3 million and a median of $28.9 million in 2022 define the central range for Depreciation & Amortization (CF).
  • Biggest five-year swings in Depreciation & Amortization (CF): dropped 0.95% in 2023 and later rose 17.76% in 2024.
  • Year by year, Depreciation & Amortization (CF) stood at $27.7 million in 2021, then grew by 3.7% to $28.7 million in 2022, then rose by 3.54% to $29.7 million in 2023, then grew by 13.35% to $33.7 million in 2024, then increased by 14.88% to $38.7 million in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for IDXX at $38.7 million in Q4 2025, $36.6 million in Q3 2025, and $35.8 million in Q2 2025.